EBIT at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's EBIT?
- Ironwood Pharmaceuticals (IRWD) reported EBIT of $72.57M in Q1 2026.
- How has Ironwood Pharmaceuticals's EBIT changed year-over-year?
- Ironwood Pharmaceuticals's EBIT increased by 349.3% year-over-year, from -$29.11M to $72.57M.
- What is the long-term trend for Ironwood Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's EBIT has grown at a -19.3% compound annual growth rate (CAGR), from $232.26M to $98.5M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.